Chiron Corp.....the month in review
Cephalon Inc. Sees Year Revs 'Substantially' Lower Than '95
Dow Jones News Service--May 15, 1996
FDA Clears HIV Home Test Sys Developed By J&J Unit
Dow Jones News Service--May 14, 1996
Nabi Inc. Starts Production Of CMV Disease-Preventing Drug
Dow Jones News Service--May 9, 1996
Fate Of Cephalon's Gehrig Disease Drug To Be Settled Soon
Dow Jones News Service--May 7, 1996
FDA Sets June 7 Review Of Cephalon/Chiron's Myotrophin
Dow Jones News Service--May 7, 1996
Business Brief -- CHIRON CORP.: Focal, Ciba Pact to Create...
The Wall Street Journal--May 3, 1996
Chiron Corp, Ciba Pharma, Focal Inc In Collaboration Pact
Dow Jones News Service--May 2, 1996
Abreast of the Market: Stocks Edge Higher as Blue Chips...
The Wall Street Journal--May 2, 1996
Health Brief -- CHIRON CORP.: Profit Totals $12.7 Million,...
The Wall Street Journal--May 1, 1996
Chiron Corp. 1Q Net 29c A Share Vs Loss $9.64 On Chgs
Dow Jones News Service--April 30, 1996
Ribozyme Pharma Gets Review Exemption From NIH Panel
Dow Jones News Service--April 26, 1996
SEC Sues Nevada Man For Insider Trading On 1994 Mergers
Dow Jones News Service--April 25, 1996
Insider Trading Spotlight
The Wall Street Journal--April 24, 1996
Chiron To Sell Its Generic Oncology Pdt Venture Stake
Dow Jones News Service--April 22, 1996
Technology & Science: Drug to Treat Gehrig's Disease To Get a...
The Wall Street Journal--April 17, 1996
Cephalon, Chiron Plan NDA Filing For Myotrophin For ALS
Dow Jones News Service--April 16, 1996
Technology & Science: Several Biotech Firms Poised to Enter...
The Wall Street Journal--April 16, 1996
Some Biotechs' 1Q Could Be The Last Losing Quarter
Dow Jones News Service--April 15, 1996
Chiron's European HCV Patent Upheld By Europe Patent Office
Dow Jones News Service--April 12, 1996 |
